Loading
Latest filing published 05 Mar 2026 for AEON Biopharma, Inc..
No signal scores available.
Alexander Blair Wilson is a declared insider of AEON Biopharma, Inc., with filings sourced from SEC (Form 4). Between 31 August 2024 and 4 March 2026, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 5 March 2026 came the latest disclosure, a share grant in AEON Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations